Macular Edema: all 847 studies
Page 6 of 9. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence TomographyStatus unknownNCT03240458
- SDM Laser for Non Central Diabetic CSMECompletedNCT03226951Not applicable
- Conbercept Ophthalmic Injection for Patients of Central Retinal Vein OcclusionCompletedNCT03223714Phase 3
- Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular EdemaCompletedNCT03211741Phase 4
- Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DMEStatus unknownNCT03197480Phase 4
- A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their DiseaseCompletedNCT03161912
- Diabetic Retinopathy Assessed by Ultra-wideStatus unknownNCT03157206
- Treatment of Diabetic Macular Edema With Aflibercept and Micropulse LaserCompletedNCT03143192Phase 2/3
- Assessment of EyeArt as an Automated Diabetic Retinopathy Screening ToolCompletedNCT03112005
- Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein OcclusionCompletedNCT03108352Phase 3
- PROTECT2: Diabetes Care - Eye ExamStatus unknownNCT03094819Not applicable
- A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)CompletedNCT03071068Phase 2
- Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal RanibizumabWithdrawnNCT03059277Phase 4
- Cytokine and Visual Outcome Variations in Eyes Receiving RanibizumabStatus unknownNCT03056092Phase 4
- Cytokine and Visual Outcome Variations in Eyes Receiving AfliberceptStatus unknownNCT03056079Phase 4
- 30g vs 33g Needle for Intravitreal InjectionsCompletedNCT03038048Not applicable
- Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)CompletedNCT03003416
- Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal MembraneTerminatedNCT02995746Not applicable
- Bevacizumabe or Triamcinolone for Persistent Diabetic Macular EdemaCompletedNCT02985619Phase 2/3
- Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular EdemaTerminatedNCT02985242Phase 4
- Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular EdemaCompletedNCT02979665
- Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201CompletedNCT02956330
- Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF InjectionCompletedNCT02933905
- Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular EdemaStatus unknownNCT02924987Phase 4
- Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular EdemaCompletedNCT02924311
- Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) StudyWithdrawnNCT02902744Phase 4
- Analyzing Retinal Microanatomy in ROPCompletedNCT02887157
- 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.WithdrawnNCT02878681Phase 4
- A Systematic Study of Retinal Structure and Function in Diabetic Macular OedemaCompletedNCT02876393
- Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular EdemaCompletedNCT02874859
- OCT-angiography in Diabetic PatientsStatus unknownNCT02870803
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular EdemaCompletedNCT02867735Phase 1
- A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular OedemaCompletedNCT02850263
- Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular EdemaWithdrawnNCT02842541Phase 1
- Adaptive Optics for Ophthalmic TechnologiesTerminatedNCT02826655Not applicable
- Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective StudyStatus unknownNCT02804360Phase 2
- The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular EdemaCompletedNCT02796183Not applicable
- Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)Status unknownNCT02788877Phase 4
- 3 Month Outcome of Ziv-aflibercept for DMECompletedNCT02772497Phase 2/3
- Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular EdemaCompletedNCT02734407Phase 4
- Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX StudyCompletedNCT02731911
- The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular EdemaStatus unknownNCT02718547Not applicable
- Epiretinal Membrane and Pseudophakic Cystoid Macular EdemaTerminatedNCT02693353
- Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal DiseasesTerminatedNCT02688309
- Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular EdemaCompletedNCT02663141Phase 2
- Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective StudyStatus unknownNCT02651168Phase 4
- Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).TerminatedNCT02650050Not applicable
- Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular EdemaCompletedNCT02646670Phase 4
- Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery PatientsCompletedNCT02646072Phase 4
- Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein OcclusionCompletedNCT02645747
- The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular EdemaStatus unknownNCT02645734Phase 2/3
- International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema PatientsCompletedNCT02639507
- Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular EdemaCompletedNCT02633852Phase 4
- Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular EdemaCompletedNCT02623673
- Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein OcclusionCompletedNCT02614937Phase 1/2
- Spectral-domain Optical Coherence Tomography of the EyeStatus unknownNCT02614625
- Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular EdemaCompletedNCT02609165Phase 2
- Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular EdemaWithdrawnNCT02598869Phase 4
- Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in CanadaCompletedNCT02585401
- Intravitreal Injections of Ziv-aflibercept for Macular DiseasesCompletedNCT02556723Not applicable
- Grid Laser for Diffuse Diabetic MaculopathyCompletedNCT02555956
- Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMaCompletedNCT02554747Not applicable
- To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.CompletedNCT02540369
- Study of DS-7080a for the Treatment of Macular DegenerationCompletedNCT02530918Phase 1
- Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 StudyWithdrawnNCT02511067Phase 2
- Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionStatus unknownNCT02486484Phase 2
- Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular EdemaTerminatedNCT02485249Phase 1/2
- Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein OcclusionCompletedNCT02478515Phase 4
- To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular EdemaStatus unknownNCT02462304Phase 4
- Photobiomodulation for the Treatment of Diabetic Macular EdemaCompletedNCT02457975Early Phase 1
- Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular OedemaCompletedNCT02457884Not applicable
- Topical Nepafenac as Supplement for Diabetic Macular EdemaCompletedNCT02443012Phase 4
- Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular EdemaCompletedNCT02441907Phase 4
- Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)CompletedNCT02432547Phase 4
- Special Drug Use Investigation of EYLEA for Diabetic Macular EdemaCompletedNCT02425501
- Phase 4 IOP Signals Associated With ILUVIEN®CompletedNCT02424019Phase 4
- Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)CompletedNCT02420132
- 577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular EdemaCompletedNCT02406157Not applicable
- Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery MacroaneurysmsStatus unknownNCT02403128Phase 1
- Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular EdemaStatus unknownNCT02399657Phase 4
- Variable Interval Versus Set Interval Aflibercept for DMECompletedNCT02392364Phase 4
- A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema PatientsCompletedNCT02359526Phase 4
- Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)WithdrawnNCT02349516Phase 2
- Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic PatientsStatus unknownNCT02337972Not applicable
- Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular EdemaCompletedNCT02329132
- Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With BiomarkersCompletedNCT02325271
- A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular DegenerationCompletedNCT02314299Phase 1/2
- Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular EdemaCompletedNCT02310295Not applicable
- Sub-threshold Photocoagulation of Diabetic Macular OedemaWithdrawnNCT02309476Not applicable
- Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity StudyCompletedNCT02308644Phase 3
- A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)CompletedNCT02302079Phase 2
- The Endurance 1 TrialCompletedNCT02297204Phase 4
- Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone AcetonideCompletedNCT02294656Phase 1
- A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular EdemaWithdrawnNCT02281292Phase 1
- Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaWithdrawnNCT02258009Phase 4
- Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKiaCompletedNCT02232503
- Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular EdemaWithdrawnNCT02229175Phase 2/3
- Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular EdemaStatus unknownNCT02227745
- Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone AcetonideCompletedNCT02221453Phase 2
- Contrast Sensitivity and Diabetic Macular EdemaCompletedNCT02217306